Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation (VX21-445-124)

ID

NCT05274269

Status

Active

DZG

DZL

Start date

05/09/2022